The family of Michael Goldsmith, a 34-year-old father of two who is on life support after being diagnosed with COVID-19, has made a desperate plea to get him the experimental drug treatment remdesivir.

The antiviral, which is awaiting regulatory approval as a coronavirus treatment, is being used in a number of clinical trials across the globe.

Goldsmith’s wife Elana told Fox News that her husband started showing coronavirus symptoms on March 11 and was diagnosed as positive on March 15. Initially sent home for self-quarantine, his condition worsened and within days, he had 104.9-degree fever. He was admitted to the hospital on March 18.

Numerous therapies, including antimalarials with antibiotics, have failed and remdesivir has been described as Goldsmith’s only hope of recovery.


Doctors at Hackensack University Medical Center in New Jersey intubated and ventilated the IT consultant on March 20 and attempted to obtain remdesivir from drugmaker Gilead Sciences’ “compassionate use” program.

“His doctors started the paperwork right away and sent it to Gilead for ‘compassionate use,’” Elana told Fox News.

That weekend, however, Gilead announced changes to its treatment program. The company implemented an “expanded access” program in an effort to enable hospitals and physicians to apply for emergency use of remdesivir for multiple severely ill patients at a time. The “compassionate use” program is now designated for children and pregnant women.

Unable to use the “compassionate use” program, doctors then attempted to get Goldsmith remdesivir as part of a clinical trial at the hospital.

When doctors received the paperwork on March 26, however, it became clear that Goldsmith was no longer eligible for the trial. A consent form from Gilead said that he could only receive remdesivir if intubated for up to four days, Elana told Fox News.

By that time, he had already been intubated for six days.

“It was very upsetting,” she added. “Thursday morning, we had been told that he had been approved and then, Thursday night, he was denied." Read more at FOX News